Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular-cholangiocarcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.

Sapisochin, Gonzalo;Javle, Milind;Lerut, Jan;Ohtsuka, Masayuki;Heimbach, Julie;et.al.
(2020) Transplantation — Vol. 104, n° 6, p. 1125-1130 (2020)

Files

Sapisochin-2020inpress-Livertransplantationforcholangiocarcinoma.pdf
  • Open Access
  • Adobe PDF
  • 1.1 MB
Download
Sapisochin-2020-Livertransplantationforcholangiocarcinoma.pdf
  • Open Access
  • Adobe PDF
  • 360.69 KB
Download

Details

Authors
  • Sapisochin, Gonzalo
    Author
  • Javle, Milind
    Author
  • Lerut, Janorcid-logoUCLouvain
    Author
  • Ohtsuka, Masayuki
    Author
  • Heimbach, Julie
    Author
Show more
Abstract
Liver transplantation for cholangiocarcinoma has been an absolute contraindication worldwide due to poor results. However, in recent years and thanks to improvements of patient management and treatments of this cancer, this indication has been revisited. This consensus paper, approved by the International Liver Transplant Society (ILTS), aims to provide a collection of expert opinions, consensus and best practices surrounding liver transplantation for cholangiocarcinoma.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Sapisochin, G., Javle, M., Lerut, J., Ohtsuka, M., Ghobrial, M., Hibi, T., Kwan, N. M., & Heimbach, J. (2020). Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular-cholangiocarcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference. Transplantation, 104(6), 1125-1130. https://doi.org/10.1097/TP.0000000000003212 (Original work published 2020)